@incollection{, 943BA0488ED0E1B939F8CD4B34DC08DD , author={{DineshDhodi} and {AmitrajitPal} and {}}, journal={{Global Journal of Medical Research}}, journal={{GJMR}}2249-46180975-588810.34257/GJMR, address={Cambridge, United States}, publisher={Global Journals Organisation}208714 } @incollection{b0, , title={{}} , journal={{Respirology}} 23 2 , year={2018} } @incollection{b1, , title={{Coronaviridae Study Group of the International Committee on Taxonomy of Viruses The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2}} , journal={{Nat Microbiol}} 5 , year={2020} } @incollection{b2, , title={{Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19}} , author={{ TRichard }} , journal={{ACS Central Science}} 6 5 , year={2020} } @incollection{b3, , title={{Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia}} , author={{ AMZaki } and { SVan Boheemen } and { TMBestebroer }} , journal={{N Engl J Med}} 367 19 , year={2012} } @incollection{b4, , title={{Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein}} , author={{ ACWalls } and { YJPark } and { MATortorici }} 10.1016/j.cell.2020.02.058 , journal={{Cell}} 181 2 , year={2020} } @incollection{b5, , title={{Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase}} , author={{ YFurata } and { TKomeno } and { TNakamura }} , journal={{Proc Jpn Acad Ser B Phys Biol Sci}} 93 7 , year={2017} } @incollection{b6, , title={{Ebola virus infection: review of the pharmacokinetic and pharmacodynamic properties of drugs considered for testing in human efficacy trials}} , author={{ VMadelain } and { THNguyen } and { AOlivo }} 10.1007/s40262-015-0364-1 , journal={{Clin Pharmacokinet}} 55 , year={2016 Aug} } @incollection{b7, , title={{Favipiravir: A new and emerging antiviral option in COVID-19}} , author={{ UAgrawal } and { RRaju } and { ZFUdwadia }} 10.1016/j.mjafi.2020.08.004 , journal={{Medical journal, Armed Forces India}} , year={2020} } @incollection{b8, , title={{Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection}} , author={{ EDe Wit } and { FFeldmann } and { JCronin }} , journal={{Proc Natl Acad Sci U S A}} 117 , year={2020} } @incollection{b9, , title={{Broadspectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses}} , author={{ TPSheahan } and { ACSims } and { RLGraham }} , journal={{Sci Transl Med}} 9 396 3653 , year={2017} } @incollection{b10, , title={{Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV}} , author={{ TPSheahan } and { ACSims } and { SRLeist }} , journal={{Nat Commun}} 11 222 , year={2020} } @incollection{b11, , title={{Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro}} , author={{ MWang } and { RCao } and { LZhang }} , journal={{Cell Res}} 30 , year={2020} } @incollection{b12, , title={{Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Additional Benefit}} , author={{ DSun }} 10.1208/s12248-020-00459-8 , journal={{The AAPS journal}} 22 4 77 , year={2020} } @incollection{b13, , title={{Cellbased Assays to Identify Inhibitors of Viral Disease}} , author={{ NGreen } and { RDOtt } and { RJIsaacs } and { HFang }} , journal={{Expert Opin. Drug Discovery}} 3 , year={2008} } @book{b14, , title={{Tocilizumab (actemra). Hum VaccinesImmunother}} , author={{ MSheppard } and { FLaskou } and { PPStapleton } and { SHadavi } and { BDasgupta }} , year={2017} 13 } @incollection{b15, , title={{Rational use of tocilizumab in the treatment of novel coronavirus pneumonia}} , author={{ SZhang } and { LLi } and { AShen } and { YChen } and { ZQi }} , journal={{Clin Drug Investig}} 40 , year={2020} } @incollection{b16, , title={{Tocilizumab for severe COVID-19: a promising intervention affecting inflammation and coagulation}} , author={{ MLevi }} , journal={{Eur J Intern Med}} 76 , year={2020} } @incollection{b17, , title={{Tocilizumab: a review of its safety and efficacy in rheumatoid arthritis}} , author={{ GJones } and { CDing }} 10.4137/CMAMD.S4864 , journal={{Clinical medicine insights. Arthritis and musculoskeletal disorders}} 3 , year={2010} } @incollection{b18, , title={{COVID-19 infection: the perspectives onimmune responses}} , author={{ YShi } and { YWang } and { CShao } and { JHuang } and { JGan } and { Xiaopingh }} , journal={{Cell Death Differ}} 27 , year={2020} } @incollection{b19, , title={{Hydroxychloroquine inhibits CD154 expression in CD4(+) T lymphocytes of systemic lupus erythematosus through NFAT, but not STAT5, signalling}} , author={{ SFWu } and { CBChang } and { JMHsu } and { MCLu } and { NSLai } and { CLi }} , journal={{Arthritis Res Ther}} 19 183 , year={2017} } @incollection{b20, , title={{Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells}} , author={{ Van Den Borne } and { Be } and { BADijkmans } and { HHDe Rooij } and { SLe Cessie } and { CLVerweij }} , journal={{J Rheumatol}} 24 , year={1997} } @incollection{b21, , title={{Intracellular transport of class II MHC molecules directed by invariant chain}} , author={{ VLotteau } and { LTeyton } and { APeleraux } and { TNilsson } and { LKarlsson } and { SLSchmid }} , journal={{Nature}} 348 , year={1990} } @incollection{b22, , title={{Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis}} , author={{ TMunster } and { JPGibbs } and { DShen } and { BABaethge } and { GRBotstein } and { JCaldwell }} 10.1002/art.10307 , journal={{Arthritis Rheum}} 46 , year={2002} } @incollection{b23, , title={{Fulminant hepatic failure secondary to hydroxychloroquine}} , author={{ AJMakin } and { JWendon } and { SFitt } and { BCPortmann } and { RWilliams }} , journal={{Gut}} 35 , year={1994} } @book{b24, , title={{}} 10.1136/gut.35.4.569 } @incollection{b25, , title={{Fatal toxic epidermal necrolysis associated with hydroxychloroquine}} , author={{ MMurphy } and { AJCarmichael }} , journal={{Clin Exp Dermatol}} 26 , year={2001} } @incollection{b26, , title={{C-reactive protein and interleukin-6 are elevated in onchocerciasis patients after ivermectin treatment}} , author={{ FLNjoo } and { CEHack } and { JOosting } and { LLuyendijk } and { JSStilma } and { AKijlstra }} 10.1208/s12248-020-00459-8 , journal={{J Infect Dis}} 170 , year={1994} } @incollection{b27, , title={{Ivermectin: potential candidate for the treatment of Covid 19}} , author={{ DGupta }} 10.1016/j.bjid.2020.06.002 , journal={{Braz J Infect Dis}} , year={2020} } @incollection{b28, , title={{The pharmacokinetics and interactions of ivermectin in humans--a mini-review}} , author={{ AGonzález Canga } and { AMSahagún Prieto } and { MJDiez Liébana } and { NFernández Martínez } and { MSierra Vega } and { JJVieitez }} 10.1208/s12248-007-9000-9 , journal={{The AAPS journal}} 10 1 , year={2008} } @book{b29, , title={{Clinical Trials Registry-India Randomised controlled trial of ivermectin in hospitalised patients with COVID19}} ID:CTRI/2020/06/026001 , note={Internet} } @book{b30, , title={{}} , author={{ MJBrooks } and { EIBurtseva } and { PJEllery } and { GAMarsh } and { AMLew } and { ANSlepushkin }} , year={2012} } @incollection{b31, , title={{Antiviral activity of arbidol, a broad-spectrum drug for use against respiratory viruses, varies according to test conditions}} , journal={{J. Med. Virol}} 84 1 } @incollection{b32, , title={{Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment}} , author={{ ZWang } and { XChen } and { YLu } and { FChen } and { WZhang }} , journal={{Biosci. Trends}} , year={2020} } @incollection{b33, , title={{Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study}} , author={{ NLian } and { HXie } and { SLin } and { JHuang } and { JZhao } and { Lin } and { Q }} , journal={{Clin. Microbiol. Infect}} , year={2020} } @book{b34, , title={{World Health Organization Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected}} } @book{b35, , title={{Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease}} , author={{ WAlhazzani } and { MMoller } and { YMArabi } and { MLoeb } and { MNGong } and { ARhodes }} 10.1002/art , year={2019} , publisher={COVID} } @incollection{b36, , title={{}} 10.1007/s00134-020-06022-5 , journal={{Intensive Care Med}} 46 , year={2020} } @book{b37, , title={{Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease}} , author={{ WAlhazzani } and { MMoller } and { YMArabi } and { MLoeb } and { MNGong } and { ARhodes }} , year={2019} , publisher={COVID} } @incollection{b38, , title={{}} 10.1007/s00134-020-06022-5 , journal={{Intensive Care Med}} 46 , year={2020} } @incollection{b39, , title={{A different look at corticosteroids}} , author={{ JZaroob } and { DCender }} , journal={{Am Fam Physician}} 58 2 , year={1998 Aug 1} } @book{b40, , title={{Role of corticosteroid in the management of COVID-19: A systemic review and a Clinician's perspective. Diabetes & metabolic syndrome}} , author={{ AKSingh } and { SMajumdar } and { RSingh } and { AMisra }} 10.1016/j.bjid.2020.06.002 , year={2020} 14 } @incollection{b41, , title={{COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up}} , author={{ BBikdeli } and { MVMadhavan } and { DJimenez } and { TChuich } and { IDreyfus } and { EDriggin }} 10.1208/s12248-007-9000-9 , journal={{J Am Coll Cardiol}} , year={April 2020} } @incollection{b42, , title={{Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia}} , author={{ LLin } and { LLu } and { WCao } and { TLi }} , journal={{Emerg Microbes Infect}} 9 1 , year={2020 Dec} } @incollection{b43, , title={{Zinc-altered immune function}} , author={{ KHIbs } and { LRink }} , journal={{J Nutr}} 133 5 , year={2003} , note={Suppl 1} } @incollection{b44, , title={{Modulating the immune response by oral zinc supplementation: a single approach for multiple diseases}} , author={{ SOverbeck } and { LRink } and { HHaase }} , journal={{Arch Immunol Ther Exp (Warsz)}} 56 , year={2008} } @incollection{b45, , title={{Office of Dietary Supplements. Zinc fact sheet for health professionals}} , journal={{National Institutes of Health}} , year={2020} } @incollection{b46, , title={{The association between vitamin D deficiency and communityacquired pneumonia: A meta-analysis of observational studies}} , author={{ YFZhou } and { BALuo } and { LLQin }} , journal={{Medicine (Baltimore)}} 98 38 e17252 , year={2019} } @incollection{b47, , title={{Vitamin C can shorten the length of stay in the ICU: a metaanalysis}} , author={{ HHemilä } and { EChalker }} , journal={{Nutrients}} 11 4 708 , year={2019} } @book{b48, , title={{Identification of amitriptyline HCl, flavin adenine dinucleotide, azacitidine and calcitriol as}} , author={{ FHuang } and { CZhang } and { QLiu } and { YZhao } and { YZhang }} , year={2020} }